Good morning, and welcome to today's call to review Aquestive Therapeutics' results for the first quarter of 2020 and business highlights. On today's call I am joined by Keith Kendall, President and
Continues to manufacture and deliver therapies and advance R&D; efforts during COVID-19 pandemic Expects to submit AQST-108 (epinephrine) IND by June 2020 and to commence PK.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 5.) Arcturus Therapeutics Ltd (...
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Some of the loans were for many times the $10 million limit; some went to companies with more than 500 employees.
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Aquestive Therapeutics ( AQST – Research Report ), with a price target of $13.00 . The company’s shares cl
At the very moment it looked like the market was down for the count, stocks bounced back. After being dealt hefty blows earlier in the week due to the record-breaking drop in oil prices, all three of
Following objections over large publicly traded companies getting forgivable loans under the Payroll Protection Program, the U.S. Treasury issues new guidance explaining that the program is meant for

Publicly-traded companies raided the PPP pantry

06:54pm, Tuesday, 21'st Apr 2020
Even with the U.S. Senate set to vote later today on passing an additional relief bill for small businesses in the U.S., there is a bright spotlight being thrown on where the funds from the original
Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, tod
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Aquestive Therapeutics ( AQST – Research Report ), with a price target of $13.00 . The company’s shares cl

ROKU, CCL among premarket gainers today

01:20pm, Tuesday, 14'th Apr 2020
Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +100%.MEI Pharma (NASDAQ:MEIP) +71% on license deal for blood cancer candidate.NantKwest (NASDAQ:NK) +39% being with ImmunityBio on active discussion
Top Ranked Momentum Stocks to Buy for April 14th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 14th
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Aquestive Therapeutics ( AQST – Research Report ), with a price target of $8.00 . The company’s shares clos
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE